G. Abou-jaoude and C. Sureau, Entry of Hepatitis Delta Virus Requires the Conserved Cysteine Residues of the Hepatitis B Virus Envelope Protein Antigenic Loop and Is Blocked by Inhibitors of Thiol-Disulfide Exchange, Journal of Virology, vol.81, issue.23, pp.13057-66, 2007.
DOI : 10.1128/JVI.01495-07

C. Albin and W. Robinson, Protein kinase activity in hepatitis B virus, J Virol, vol.34, pp.297-302, 1980.

J. Allain, Epidemiology of Hepatitis B virus and genotype, Journal of Clinical Virology, vol.36, issue.1, pp.12-19, 2006.
DOI : 10.1016/S1386-6532(06)80003-X

J. Almeida, D. Rubenstein, and E. Stott, New antigen-antibody system in Australia-antigenpositive hepatitis, Lancet, vol.2, issue.7736, pp.1225-1232, 1971.

N. Araujo, C. Vianna, M. Moraes, and S. Gomes, Expression of Hepatitis B virus antigen (HBs Ag) from genotypes A, D and F and influence of amino acid variations related or not to genotypes on HBs Ag detection, Braz J Infect Dis, vol.13, issue.4, pp.266-71, 2009.

P. Arauz-ruiz, H. Norder, B. Robertson, and L. Magnius, Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America, Journal of General Virology, vol.41, issue.8, pp.2059-73, 2002.
DOI : 10.1172/JCI115500

W. Bancroft, F. Mundon, and P. Russell, Detection of additional antigenic determinants of hepatitis B antigen, J Immunol, vol.109, issue.4, pp.842-850, 1972.

R. Bartenschlager and H. Schaller, Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome, EMBO J, vol.11, issue.9, pp.3413-3433, 1992.

D. Bhattacharya and C. Thio, Review of Hepatitis B Therapeutics, Clinical Infectious Diseases, vol.51, issue.10, pp.1201-1209, 2010.
DOI : 10.1086/656624

M. Bayer, B. Blumberg, and B. Werner, Particles associated with Australia Antigen in the Sera of Patients with Leukaemia, Down's Syndrome and Hepatitis, Nature, vol.218, issue.5146, pp.1057-1066, 1968.
DOI : 10.1038/2181057a0

J. Beck and M. Nassal, Hepatitis B virus replication, World Journal of Gastroenterology, vol.13, issue.1, pp.48-64, 2007.
DOI : 10.3748/wjg.v13.i1.48

A. Bertoletti and C. Ferrari, Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection, Gut, vol.61, issue.12, pp.1754-64, 2012.
DOI : 10.1136/gutjnl-2011-301073

M. Blanchet and C. Sureau, Infectivity Determinants of the Hepatitis B Virus Pre-S Domain Are Confined to the N-Terminal 75 Amino Acid Residues, Journal of Virology, vol.81, issue.11, pp.5841-5850, 2007.
DOI : 10.1128/JVI.00096-07

B. Blumberg, Australia antigen and the biology of hepatitis B, Science, vol.197, issue.4298, pp.17-25, 1977.
DOI : 10.1126/science.325649

B. Blumberg, The discovery of the hepatitis B virus and the invention of the vaccine: A scientific memoir, Journal of Gastroenterology and Hepatology, vol.17, issue.s4, pp.502-505, 2002.
DOI : 10.1046/j.1440-1746.17.s4.19.x

B. Blumberg, H. Alter, and S. Visnich, A " new " antigen in leukemia sera, JAMA, vol.191, issue.7, pp.514-520, 1965.

B. Blumberg, B. Gerstley, D. Hungerford, W. London, and A. Sutnick, A Serum Antigen (Australia Antigen) in Down's Syndrome, Leukemia, and Hepatitis, Annals of Internal Medicine, vol.66, issue.5, pp.924-955, 1967.
DOI : 10.7326/0003-4819-66-5-924

V. Bosch, R. Bartenschlager, G. Radziwill, and H. Schaller, The duck hepatitis B virus P-gene codes for protein strongly associated with the 5???-end of the viral dna minus strand, Virology, vol.166, issue.2, pp.475-85, 1988.
DOI : 10.1016/0042-6822(88)90518-1

C. Bremer, C. Bung, N. Kott, M. Hardt, and D. Glebe, Hepatitis B virus infection is dependent on cholesterol in the viral envelope, Cellular Microbiology, vol.1768, issue.2, pp.249-60, 2009.
DOI : 10.3748/wjg.v13.i1.14

Y. Wang, S. Hadziyannis, E. Wolf, P. Mccloud, R. Batrla et al., Hepatitis B virus surface antigen levels: a guide to sustained response to Peginterferon alpha-2a in HBeAg-Negative chronic hepatitis B, Hepatology, vol.49, issue.4, pp.1141-50, 2009.

M. Brunetto, F. Oliveri, P. Colombatto, F. Moriconi, P. Ciccorossi et al., Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers, Gastroenterology, vol.139, issue.2, pp.483-90, 2010.
DOI : 10.1053/j.gastro.2010.04.052

V. Bruss, Hepatitis B virus morphogenesis, World Journal of Gastroenterology, vol.13, issue.1, pp.65-73, 2007.
DOI : 10.3748/wjg.v13.i1.65

W. Carman, The clinical significance of surface antigen variants of hepatitis B virus, Journal of Viral Hepatitis, vol.22, issue.s1, pp.11-20, 1997.
DOI : 10.1111/j.1365-2893.1995.tb00024.x

H. Tillmann, J. Kao, J. Jia, H. Wedemeyer, S. Locarnini et al., Hepatitis B surface antigen quantification: why and how to use it in 2011 -a core group report, J Hepatol, vol.55, issue.5, pp.1121-1152, 2011.

S. Chang, H. Netter, M. Bruns, R. Schneider, K. Frölich et al., A New Avian Hepadnavirus Infecting Snow Geese (Anser caerulescens) Produces a Significant Fraction of Virions Containing Single-Stranded DNA, Virology, vol.262, issue.1, pp.39-54, 1999.
DOI : 10.1006/viro.1999.9844

F. Chisari, M. Isogawa, and S. Wieland, Pathogenesis of hepatitis B virus infection, Pathologie Biologie, vol.58, issue.4, pp.258-66, 2010.
DOI : 10.1016/j.patbio.2009.11.001

S. Ciesek, F. Helfritz, U. Lehmann, T. Becker, C. Strassburg et al., Persistence of Occult Hepatitis B after Removal of the Hepatitis B Virus???Infected Liver, The Journal of Infectious Diseases, vol.69, issue.3, pp.355-60, 2008.
DOI : 10.1002/hep.20507

P. Coleman, Detecting Hepatitis B Surface Antigen Mutants, Emerging Infectious Diseases, vol.12, issue.2, pp.198-203, 2006.
DOI : 10.3201/eid1203.050038

D. Dane, C. Cameron, and M. Briggs, Virus-like particles in serum of patients with Australiaantigen-associated hepatitis, Lancet, vol.1, issue.7649, pp.695-703, 1970.

K. Basu, A. Basu, S. Datta, A. Chowdhury, and S. Banerjee, Novel point and combo mutations in the genome of hepatitis B virus genotype D: characterization and impact on liver disease progression to hepatocellular carcinoma, PLoS One, vol.9, p.110012, 2014.

A. Dawson, An ethical argument in favour of routine hepatitis B vaccination in very low-incidence countries, The Lancet Infectious Diseases, vol.5, issue.2, pp.120-125, 2005.
DOI : 10.1016/S1473-3099(05)70087-6

W. Delaney, Molecular virology of chronic hepatitis B and C: Parallels, contrasts and impact on drug development and treatment outcome, Antiviral Research, vol.99, issue.1, pp.34-48, 2013.
DOI : 10.1016/j.antiviral.2013.04.010

G. Deléage, C. Combet, C. Blanchet, and C. Geourjon, ANTHEPROT: An integrated protein sequence analysis software with client/server capabilities, Computers in Biology and Medicine, vol.31, issue.4, pp.259-67, 2001.
DOI : 10.1016/S0010-4825(01)00008-7

E. Ebranati, A. Cargnel, R. Bruno, M. Galli, and G. Zehender, High level of genetic heterogeneity in S and P genes of genotype D hepatitis B virus, Virology, vol.365, pp.113-137, 2007.

P. Dény and F. Zoulim, Hepatitis B virus: From diagnosis to treatment, Pathologie Biologie, vol.58, issue.4, pp.245-53, 2010.
DOI : 10.1016/j.patbio.2010.05.002

C. Desmond, A. Batholomeusz, S. Gaudieri, P. Revill, and S. Lewin, A systematic review of Tcell epitopes in hepatitis B virus : identification, genotypic variation and relevance to antiviral therapeutics, Antiviral Therapy, vol.13, pp.161-75, 2008.

F. Zoulim, A new strategy for studying In Vitro the drug susceptibility of clinical isolates of Human Hepatitis B Virus, Hepatology, vol.40, issue.4, pp.855-64, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-00137151

D. Durantel, Fitness and infectivity of drug-resistant and cross-resistant hepatitis B virus mutants: why and how is it studied?, Antiviral Therapy, vol.15, issue.3 Part B, pp.521-548, 2010.
DOI : 10.3851/IMP1551

URL : https://hal.archives-ouvertes.fr/inserm-00490020

M. Fasano, P. Lampertico, A. Marzano, D. Marco, V. Niro et al., HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5years, Journal of Hepatology, vol.56, issue.6, pp.1254-1262, 2012.
DOI : 10.1016/j.jhep.2012.01.022

G. Fattovich, F. Bortolotti, and F. Donato, Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors, Journal of Hepatology, vol.48, issue.2, pp.335-52, 2008.
DOI : 10.1016/j.jhep.2007.11.011

F. Galibert, E. Mandart, F. Fitoussi, P. Tiollais, and P. Charnay, Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli, Nature, vol.5, issue.5733, pp.281-646, 1979.
DOI : 10.1016/0092-8674(78)90070-3

W. Gerlich and W. Robinson, Hepatitis B virus contains protein attached to the 5??? terminus of its complete DNA strand, Cell, vol.21, issue.3, pp.801-810, 1980.
DOI : 10.1016/0092-8674(80)90443-2

J. Giles, R. Mccollum, L. Berndtson, . Jr, and S. Krugman, Viral Hepatitis, New England Journal of Medicine, vol.281, issue.3, pp.119-141, 1969.
DOI : 10.1056/NEJM196907172810302

URL : https://hal.archives-ouvertes.fr/pasteur-01567827

R. Tamez and L. Of, HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B, J Viral Hepat, vol.17, issue.1, pp.16-22, 2010.

D. Glebe, Recent advances in hepatitis B virus research: A German point of view, World Journal of Gastroenterology, vol.13, issue.1, pp.8-13, 2007.
DOI : 10.3748/wjg.v13.i1.8

D. Glebe and S. Urban, Viral and cellular determinants involved in hepadnaviral entry, World Journal of Gastroenterology, vol.13, issue.1, pp.22-38, 2007.
DOI : 10.3748/wjg.v13.i1.22

D. Gocke and N. Kavey, Hepatitis antigen. Correlation with disease and infectivity of blooddonors, Lancet, vol.1, issue.7605, pp.1055-1064, 1969.

H. Greenberg, R. Pollard, L. Lutwick, P. Gregory, W. Robinson et al., Effect of Human Leukocyte Interferon on Hepatitis B Virus Infection in Patients with Chronic Active Hepatitis, New England Journal of Medicine, vol.295, issue.10, pp.517-539, 1976.
DOI : 10.1056/NEJM197609022951001

S. Grethe, J. Heckel, W. Rietschel, and F. Hufert, Molecular Epidemiology of Hepatitis B Virus Variants in Nonhuman Primates, Journal of Virology, vol.74, issue.11, pp.5377-81, 2000.
DOI : 10.1128/JVI.74.11.5377-5381.2000

D. Grimm, R. Thimme, and H. Blum, HBV life cycle and novel drug targets, Hepatology International, vol.25, issue.10, pp.644-53, 2011.
DOI : 10.1016/j.vaccine.2006.11.019

URL : http://europepmc.org/articles/pmc3090558?pdf=render

P. Gripon, I. Canie, and S. Urban, Efficient Inhibition of Hepatitis B Virus Infection by Acylated Peptides Derived from the Large Viral Surface Protein, Journal of Virology, vol.79, issue.3, pp.1613-1635, 2005.
DOI : 10.1128/JVI.79.3.1613-1622.2005

P. Gripon, C. Diot, and C. Guguen-guillouzo, Myristylation of the Hepatitis B Virus Large Surface Protein Is Essential for Viral Infectivity, Virology, vol.213, issue.2, pp.292-301, 1995.
DOI : 10.1006/viro.1995.0002

P. Gripon, C. Diot, N. Theze, I. Fourel, O. Loreal et al., Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide, J Virol, vol.62, issue.1, pp.4136-4179, 1988.

P. Gripon, S. Rumin, S. Urban, L. Seyec, J. Glaise et al., Infection of a human hepatoma cell line by hepatitis B virus, Proc Natl Acad Sci U.S.A, issue.24, pp.99-15655, 2002.

P. Gripon, I. Cannie, and S. Urban, Efficient Inhibition of Hepatitis B Virus Infection by Acylated Peptides Derived from the Large Viral Surface Protein, Journal of Virology, vol.79, issue.3, pp.1613-1635, 2005.
DOI : 10.1128/JVI.79.3.1613-1622.2005

L. Guidotti and F. Chisari, IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS, Annual Review of Pathology: Mechanisms of Disease, vol.1, issue.1
DOI : 10.1146/annurev.pathol.1.110304.100230

DOI : 10.1084/jem.83.6.441

J. Hayer, F. Jadeau, G. Deléage, A. Kay, F. Zoulim et al., HBVdb: a knowledge database for Hepatitis B Virus, Nucleic Acids Research, vol.25, issue.3, pp.566-70, 2013.
DOI : 10.1016/S0968-0004(99)01540-6

URL : https://hal.archives-ouvertes.fr/hal-00965883

J. Sorbel and F. Rousseau, Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B, Gastroenterology, vol.140, issue.1, pp.132-175, 2011.

K. Heermann, U. Goldmann, W. Schwartz, T. Seyffarth, H. Baumgarten et al., Large surface proteins of hepatitis B virus containing the pre-s sequence, J Virol, vol.52, issue.2, pp.396-402, 1984.

W. Hillis, An outbreak of infectious hepatitis among chimpanzee handlers at a United States Air Force Base, Am J Hyg, vol.73, pp.316-344, 1961.

T. Hosaka, F. Suzuki, M. Kobayashi, Y. Seko, Y. Kawamura et al., Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study, Journal of Gastroenterology, vol.34, issue.8, pp.930-971, 2013.
DOI : 10.1053/jhep.2001.28459

A. Kramvis, M. Kew, and G. François, Hepatitis B virus genotypes, Vaccine, vol.23, issue.19, pp.2409-2432, 2005.
DOI : 10.1016/j.vaccine.2004.10.045

M. Kuo, M. Chao, and J. Taylor, Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen, J. Virol, vol.63, pp.1945-50, 1989.

F. Kurbanov, Y. Tanaka, and M. Mizokami, Geographical and genetic diversity of the human hepatitis B virus, Hepatology Research, vol.89, issue.1, pp.14-30, 2010.
DOI : 10.1099/0022-1317-81-9-2267

R. Lanford, D. Chavez, K. Brasky, R. Burns, and R. Rico-hesse, Isolation of a hepadnavirus from the woolly monkey, a New World primate, Proceedings of the National Academy of Sciences, vol.176, issue.4, pp.955757-61, 1998.
DOI : 10.1086/516507

S. Laperche, A. Servant-delmas, P. Gallian, and J. Pillonel, La surveillance de la diversité des virus VIH, VHB et VHC chez les donneurs de sang français entre, Bull Epidémiol Hebd, pp.39-40447, 2000.

L. Duff, Y. Blanchet, M. Sureau, and C. , The Pre-S1 and Antigenic Loop Infectivity Determinants of the Hepatitis B Virus Envelope Proteins Are Functionally Independent, Journal of Virology, vol.83, issue.23, pp.12443-51, 2009.
DOI : 10.1128/JVI.01594-09

C. Leistner, S. Gruen-bernhard, and D. Glebe, Role of glycosaminoglycans for binding and infection of hepatitis B virus, Cellular Microbiology, vol.86, issue.0, pp.122-155, 2008.
DOI : 10.1016/S1386-6532(06)80010-7

Y. Lew and T. Michalak, In Vitro and In Vivo Infectivity and Pathogenicity of the Lymphoid Cell-Derived Woodchuck Hepatitis Virus, Journal of Virology, vol.75, issue.4, pp.1770-82, 2001.
DOI : 10.1128/JVI.75.4.1770-1782.2001

L. Li, R. Dixon, X. Gu, and J. Newbold, Comparison of the sequences of the Grey Teal, Maned Duck and Duck Hepatitis B Viruses. In The molecular biology of Hepatitis B Virus. The United States, p.13, 1998.

S. Locarnini and L. Yuen, Molecular genesis of drug-resistant and vaccine-escape HBV mutants, Antiviral Therapy, vol.15, issue.3 Part B, pp.451-61, 2010.
DOI : 10.3851/IMP1499

W. London, A. Sutnick, and B. Blumberg, Australia Antigen and Acute Viral Hepatitis, Annals of Internal Medicine, vol.70, issue.1, pp.55-64, 1969.
DOI : 10.7326/0003-4819-70-1-55

G. Villa and E. , Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: sequence analysis and therapeutic strategy, J Clin Virol, vol.62, pp.89-91, 2015.

F. Maccallum, HOMOLOGOUS SERUM HEPATITIS, The Lancet, vol.252, issue.6525, pp.691-693, 1947.
DOI : 10.1016/S0140-6736(48)91064-2

L. Magnius and A. Espmark, A new antigen complex co-occuring with Australia antigen, Acta Pathol Microbiol Scand B Microbiol Immunol, vol.80, issue.2, pp.335-342, 1972.

L. Magnius and J. Espmark, New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants, J Immunol, vol.109, issue.5, pp.1017-1038, 1972.

C. Mangold, F. Unckell, M. Werr, and R. Streeck, Secretion and Antigenicity of Hepatitis B Virus Small Envelope Proteins Lacking Cysteines in the Major Antigenic Region, Virology, vol.211, issue.2, pp.535-578, 1995.
DOI : 10.1006/viro.1995.1435

P. Marcellin, T. Asselah, O. Lada, and . Treatment, Traitement ?? ?? la carte ?? de l???h??patite chronique B, Gastroent??rologie Clinique et Biologique, vol.32, issue.1, pp.1-5, 2008.
DOI : 10.1016/S0399-8320(08)73258-5

J. Quinn and F. Rousseau, Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B, N Engl J Med, vol.359, issue.23, pp.2442-55, 2008.

P. Marcellin, E. Gane, M. Buti, N. Afdhal, W. Sievert et al., Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study, The Lancet, vol.381, issue.9865, pp.381468-75, 2013.
DOI : 10.1016/S0140-6736(12)61425-1

P. Marion, L. Oshiro, D. Regnery, G. Scullard, and W. Robinson, A virus in Beechey ground squirrels that is related to hepatitis B virus of humans., Proceedings of the National Academy of Sciences, vol.77, issue.5, pp.2941-2946, 1980.
DOI : 10.1073/pnas.77.5.2941

M. Martinot-peignoux, R. Carvalho-filho, M. Lapalus, F. Netto-cardoso, A. Lada et al., Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-na??ve, e antigen-positive patients, Journal of Hepatology, vol.58, issue.6, pp.1089-95, 2013.
DOI : 10.1016/j.jhep.2013.01.028

W. Mason, G. Seal, and J. Summers, Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus, J Virol, vol.36, pp.829-865, 1980.

A. Matsumoto, E. Tanaka, S. Morita, K. Yoshizawa, T. Umemura et al., Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection, Journal of Gastroenterology, vol.42, issue.Suppl 1, pp.1006-1019, 2012.
DOI : 10.1111/j.1872-034X.2011.00910.x

P. Maupas, A. Goudeau, P. Coursaget, J. Drucker, and P. Bagros, IMMUNISATION AGAINST HEPATITIS B IN MAN, The Lancet, vol.307, issue.7974, pp.1367-70, 1976.
DOI : 10.1016/S0140-6736(76)93023-3

P. Maupas, A. Goudeau, P. Coursaget, J. Drucker, P. Baudin et al., Vaccine against hepatitis B ??? 18 months prevention in a high risk setting, Medical Microbiology and Immunology, vol.182, issue.1-4, pp.1-4109, 1978.
DOI : 10.1016/0304-4165(64)90438-6

J. Desenclos, Prevalence of Hepatitis B and Hepatitis C Virus infections in France in 2004: Social factors are important predictors after adjusting for known risk factors, J. Med. Virol, vol.82, pp.546-55, 2010.

A. Meier, S. Mehrle, T. Weiss, W. Mier, and S. Urban, Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes, Hepatology, vol.110, issue.5 Suppl 1, pp.31-42, 2013.
DOI : 10.1053/gast.1996.v110.pm8613059

R. Moucari and P. Marcellin, Quantification of hepatitis B surface antigen: a new concept for the management of chronic hepatitis B, Liver International, vol.127, issue.(S, pp.122-130, 2011.
DOI : 10.1016/0016-5085(93)91082-S

J. Murray, S. Wieland, R. Purcell, and F. Chisari, Dynamics of hepatitis B virus clearance in chimpanzees, Proceedings of the National Academy of Sciences, vol.69, issue.10, pp.17780-17785, 2005.
DOI : 10.1128/JVI.74.11.5257-5265.2000

H. Naumann, S. Schaefer, C. Yoshida, A. Gaspar, R. Repp et al., Identification of a new hepatitis B virus (HBV) genotype from Brazil that expresses HBV surface antigen subtype adw4, Journal of General Virology, vol.74, issue.8, pp.1627-1659, 1993.
DOI : 10.1099/0022-1317-74-8-1627

G. Nebbia, D. Peppa, and M. Maini, Hepatitis B infection: current concepts and future challenges, QJM, vol.30, issue.11
DOI : 10.1002/1521-4141(200011)30:11<3067::AID-IMMU3067>3.0.CO;2-L

URL : https://academic.oup.com/qjmed/article-pdf/105/2/109/4476470/hcr270.pdf

Y. Ni, F. Lempp, S. Mehrle, S. Nkongolo, C. Kaufman et al., Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes, Gastroenterology, vol.146, issue.4, pp.1070-83, 2014.
DOI : 10.1053/j.gastro.2013.12.024

H. Norder, J. Ebert, H. Fields, I. Mushahwar, and L. Magnius, Complete Sequencing of a Gibbon Hepatitis B Virus Genome Reveals a Unique Genotype Distantly Related to the Chimpanzee Hepatitis B Virus, Virology, vol.218, issue.1, pp.214-237, 1996.
DOI : 10.1006/viro.1996.0181

M. Nowak, S. Bonhoeffer, A. Hill, R. Boehme, H. Thomas et al., Viral dynamics in hepatitis B virus infection., Proceedings of the National Academy of Sciences, vol.93, issue.9, pp.4398-402, 1996.
DOI : 10.1073/pnas.93.9.4398

J. Parker, D. Guo, and R. Hodges, New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and x-ray-derived accessible sites, Biochemistry, vol.25, issue.19, pp.5425-5457, 1986.
DOI : 10.1021/bi00367a013

R. Patient, C. Hourioux, P. Sizaret, S. Trassard, C. Sureau et al., Hepatitis B Virus Subviral Envelope Particle Morphogenesis and Intracellular Trafficking, Journal of Virology, vol.81, issue.8, pp.3842-51, 2007.
DOI : 10.1128/JVI.02741-06

C. Semaille and C. Larsen, Hépatite B chronique : prise en charge en France entre, 2008.

S. Pol, Histoire naturelle de l???infection par le virus de l???h??patite B, La Presse M??dicale, vol.35, issue.2, pp.308-324, 2006.
DOI : 10.1016/S0755-4982(06)74576-6

T. Pollicino, I. Cacciola, F. Saffioti, and G. Raimondo, Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications, Journal of Hepatology, vol.61, issue.2, pp.408-425, 2014.
DOI : 10.1016/j.jhep.2014.04.041

T. Pollicino, L. Belloni, G. Raffa, N. Pediconi, G. Squadrito et al., Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones, Gastroenterology, vol.130, issue.3, pp.823-860, 2006.
DOI : 10.1053/j.gastro.2006.01.001

M. Pourkarim, S. Amini-bavil-olyaee, J. Verbeeck, P. Lemey, M. Zeller et al., Molecular evolutionary analysis and mutational pattern of full-length genomes of hepatitis B virus isolated from Belgian patients with different clinical manifestations, Journal of Medical Virology, vol.357, issue.3, pp.379-89, 2010.
DOI : 10.2174/0929867043364333

H. Sirma, New hepatitis B virus of cranes that has an unexpected broad host range, J Virol, vol.77, issue.3, pp.1964-76, 2003.

A. Prince, An antigen detected in the blood during the incubation period of serum hepatitis., Proceedings of the National Academy of Sciences, vol.60, issue.3
DOI : 10.1073/pnas.60.3.814

O. Krone, E. Kaleta, and H. Will, Identification and Analysis of a New Hepadnavirus in White Storks, Virology, vol.289, pp.114-142, 2001.

H. Popper, E. Lvovsky, D. Wong, and H. Levy, Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer, Lancet, vol.2, issue.7989, pp.757-61, 1976.

E. Domingo and S. Jazayeri, Mutation hot spots in hepatitis B surface antigen in chronic carriers from Khoozestan province, southern of Iran, Iran J Allergy Asthma Immunol, vol.12, issue.3, pp.269-75, 2013.

W. Robinson, D. Clayton, and R. Greenman, DNA of a human hepatitis B virus candidate, J Virol, vol.14, issue.2, pp.384-91, 1974.

. Cuba, Absence of West-African Genotypes despite the Transatlantic Slave Trade, PLoS One, vol.10, issue.5, p.125052, 2015.

J. Salisse and C. Sureau, A function essential to viral entry underlies the HBV « a » determinant

F. Sattler and W. Robinson, Hepatitis B viral DNA molecules have cohesive ends, J Virol, vol.32, issue.1, pp.226-259, 1979.

S. Schaefer, Hepatitis B virus taxonomy and hepatitis B virus genotypes, World Journal of Gastroenterology, vol.13, issue.1, pp.14-21, 2007.
DOI : 10.3748/wjg.v13.i1.14

P. André and P. Dény, Standardized One-Step Real-Time Reverse transcription-PCR assay for universal detection and quantification of hepatitis Delta virus from clinical samples in the presence of a heterologous internal-control RNA, JCM, vol.50, pp.2126-2134, 2012.

A. Schulze, P. Gripon, and S. Urban, Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans, Hepatology, vol.79, issue.6, pp.1759-68, 2007.
DOI : 10.1128/JVI.79.16.10460-10466.2005

URL : https://hal.archives-ouvertes.fr/hal-00690474

A. Schulze, A. Schieck, Y. Ni, W. Mier, and S. Urban, Fine Mapping of Pre-S Sequence Requirements for Hepatitis B Virus Large Envelope Protein-Mediated Receptor Interaction, Journal of Virology, vol.84, issue.4, pp.1989-2000, 2010.
DOI : 10.1128/JVI.01902-09

C. Seeger and W. Mason, Hepatitis B Virus Biology, Microbiology and Molecular Biology Reviews, vol.64, issue.1, pp.51-68, 2000.
DOI : 10.1128/MMBR.64.1.51-68.2000

C. Seeger, D. Ganem, and H. Varmus, Biochemical and genetic evidence for the hepatitis B virus replication strategy, Science, vol.232, issue.4749, pp.477-84, 1986.
DOI : 10.1126/science.3961490

J. Senior, A. Sutnick, E. Goeser, W. London, M. Dahike et al., Reduction of post-transfusion hepatitis by exclusion of Australia antigen from donor blood in an urban public hospital, THE AMERICAN JOURNAL OF THE MEDICAL SCIENCES, vol.267, issue.3, pp.171-178, 1974.
DOI : 10.1097/00000441-197403000-00004

A. Septfons, A. Gautier, C. Brouard, P. Bernillon, J. Nicolau et al., Prévalence, morbidité et mortalité associées aux hépatites B et C chroniques dans la population hospitalisée en France, Bull epidémiol Hebd, issue.12, pp.202-211, 2004.

M. Sonneveld, V. Rijckborst, Y. Cakaloglu, K. Simon, E. Heathcote et al., Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-??2b: relation to response and HBV genotype, Antiviral Therapy, vol.17, issue.1, pp.9-17, 2012.
DOI : 10.3851/IMP1887

R. Sprengel, E. Kaleta, and H. Will, Isolation and characterization of a hepatitis B virus endemic in herons, J Virol, vol.62, pp.3832-3841, 1998.

J. Summers and W. Mason, Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate, Cell, vol.29, issue.2, pp.403-418, 1982.
DOI : 10.1016/0092-8674(82)90157-X

J. Summers, O. Connell, A. Millman, and I. , Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles., Proceedings of the National Academy of Sciences, vol.72, issue.11, pp.724597-4601, 1975.
DOI : 10.1073/pnas.72.11.4597

J. Summers, J. Smolec, and R. Snyder, A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks., Proceedings of the National Academy of Sciences, vol.75, issue.9, pp.4533-4540, 1978.
DOI : 10.1073/pnas.75.9.4533

T. Au, K. Tsoi, S. Locarnini, and H. Chan, Genome-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus, J Virol, vol.82, pp.3604-3615, 2008.

C. Sureau, The Use of Hepatocytes to Investigate HDV Infection: The HDV/HepaRG Model
DOI : 10.1007/978-1-60761-688-7_25

C. Sureau, B. Guerra, and H. Lee, The middle hepatitis B virus envelope protein is not necessary for infectivity of hepatitis delta virus, J Virol, vol.68, pp.4063-4069, 1994.

C. Sureau and J. Salisse, A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus A-determinant, Hepatology, vol.35, issue.Suppl. 1, pp.985-94, 2013.
DOI : 10.1016/S0161-5890(98)00110-2

S. Taffon, D. Genovese, M. Blasi, P. Pierotti, D. Esposti et al., HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up study, Infection, vol.163, issue.4, pp.675-87, 2014.
DOI : 10.1016/j.virusres.2011.09.029

P. Tai, F. Suk, W. Gerlich, A. Neurath, and C. Shih, Hypermodification and Immune Escape of an Internally Deleted Middle-Envelope (M) Protein of Frequent and Predominant Hepatitis B Virus Variants, Virology, vol.292, issue.1, pp.44-58, 2002.
DOI : 10.1006/viro.2001.1239

K. Tatematsu, Y. Tanaka, F. Kurbanov, F. Sugauchi, S. Mano et al., A Genetic Variant of Hepatitis B Virus Divergent from Known Human and Ape Genotypes Isolated from a Japanese Patient and Provisionally Assigned to New Genotype J, Journal of Virology, vol.83, issue.20, pp.10538-10585, 2009.
DOI : 10.1128/JVI.00462-09

J. Taylor, Virus entry mediated by hepatitis B virus envelope proteins, World Journal of Gastroenterology, vol.19, issue.40, pp.6730-6764, 2013.
DOI : 10.3748/wjg.v19.i40.6730

M. Buendia, A new hepadnavirus endemic in artic ground squirrels in Alaska, J Virol, vol.70, issue.7, pp.4210-4219, 1996.

R. Thomas, D. Lorenzetti, and W. Spragins, Mortality and Morbidity Among Military Personnel and Civilians During the 1930s and World War II From Transmission of Hepatitis During Yellow Fever Vaccination: Systematic Review, American Journal of Public Health, vol.103, issue.3, pp.16-29, 2013.
DOI : 10.2105/AJPH.2012.301158

S. Tong, J. Li, J. Wands, and Y. Wen, Hepatitis B virus genetic variants: biological properties and clinical implications, Emerging Microbes & Infections, vol.78, issue.3, p.10, 2013.
DOI : 10.1128/CMR.00018-11

J. Torresi, The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus, Journal of Clinical Virology, vol.25, issue.2, pp.97-106, 2002.
DOI : 10.1016/S1386-6532(02)00049-5

T. Tran, T. Trinh, and K. Abe, New complex recombinant genotype of hepatitis B virus identified in Vietnam, J Virol, vol.82, issue.11, pp.5657-63, 2008.

C. Trepo, A brief history of hepatitis milestones, Liver International, vol.17, issue.Suppl. 1, pp.29-37, 2014.
DOI : 10.1111/j.1365-2893.2009.01246.x

C. Tseng, K. Jeng, and M. Lai, Transcription of Subgenomic mRNA of Hepatitis Delta Virus Requires a Modified Hepatitis Delta Antigen That Is Distinct from Antigenomic RNA Synthesis, Journal of Virology, vol.82, issue.19, pp.9409-9425, 2008.
DOI : 10.1128/JVI.00428-08

S. Urban, A. Schulze, M. Dandri, and J. Petersen, The replication cycle of hepatitis B virus, Journal of Hepatology, vol.52, issue.2, pp.282-286, 2010.
DOI : 10.1016/j.jhep.2009.10.031

S. Urban, R. Bartenschlager, R. Kubitz, and F. Zoulim, Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes, Gastroenterology, vol.147, issue.1, pp.48-64, 2014.
DOI : 10.1053/j.gastro.2014.04.030

M. Vaudin, A. Wolstenholme, K. Tsiquaye, A. Zuckerman, and T. Harrison, The Complete Nucleotide Sequence of the Genome of a Hepatitis B Virus Isolated from a Naturally Infected Chimpanzee, Journal of General Virology, vol.69, issue.6, pp.1383-1392, 1988.
DOI : 10.1099/0022-1317-69-6-1383

V. Velu, S. Saravanan, S. Nandakumar, E. Dhevahi, E. Shankar et al., Transmission of "a" determinant variants of hepatitis B virus in immunized babies born to HBsAg carrier mothers, Jpn J Infect Dis, vol.61, issue.1, pp.73-79, 2008.

E. Verrier, C. Colpitts, C. Bach, L. Heydmann, A. Weiss et al., A targeted functional RNAi screen uncovers Glypican 5 as an entry factor for hepatitis B and D viruses, Hepatology, 2015.

S. Villet, G. Billioud, C. Pichoud, J. Lucifora, O. Hantz et al., In Vitro Characterization of Viral Fitness of Therapy-Resistant Hepatitis B Variants, Gastroenterology, vol.136, issue.1, pp.168-76, 2009.
DOI : 10.1053/j.gastro.2008.09.068

E. Walter, R. Keist, B. Niederöst, I. Pult, and H. Blum, Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo, Hepatology, vol.24, issue.1, pp.1-5, 1996.
DOI : 10.1053/jhep.1996.v24.pm0008707245

N. Warner and S. Locarnini, The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound, Hepatology, vol.4, issue.1, pp.88-98, 2008.
DOI : 10.1002/hep.22295

K. Warren, J. Heeney, R. Swan, . Heriyanto, and E. Verschoor, A new group of hepadnaviruses naturally infecting orangutans (Pongo pygmaeus), J Virol, vol.73, pp.7860-7865, 1999.

K. Watashi, S. Urban, W. Li, and T. Wakita, NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry, International Journal of Molecular Sciences, vol.10, issue.2, pp.2892-905, 2014.
DOI : 10.1021/mp300453k

B. Weber, Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact, Journal of Clinical Virology, vol.32, issue.2, pp.102-114, 2005.
DOI : 10.1016/j.jcv.2004.10.008

Y. Wei, C. Neuveut, P. Tiollais, and M. Buendia, Molecular biology of the hepatitis B virus and role of the X gene, Pathologie Biologie, vol.58, issue.4, pp.267-72, 2010.
DOI : 10.1016/j.patbio.2010.03.005

Y. Xie, J. Zhai, Q. Deng, P. Tiollais, Y. Wang et al., Entry of hepatitis??B virus: Mechanism and new therapeutic target, Pathologie Biologie, vol.58, issue.4, pp.301-308, 2010.
DOI : 10.1016/j.patbio.2010.04.001

H. Yan, G. Zhong, G. Xu, W. He, Z. Jing et al., Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus, Elife, vol.1, p.49, 2012.

J. Petersen, M. Fasano, M. Buti, T. Berg, B. Hansen et al., Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis, Gut, vol.62, issue.5, pp.760-765, 2013.